Sharon Ann Hunt

Q: What Schools Are Affiliated With Sharon Ann Hunt

Sharon Ann Hunt is affiliated with the following schools: Stanford University, Johns Hopkins University, University of Virginia, Harvard University

Sharon Ann Hunt's AcademicInfluence.com Rankings

Sharon Ann Hunt

Medical

#1805

World Rank

#2181

Historical Rank

#424

USA Rank

Cardiology

#185

World Rank

#190

Historical Rank

#14

USA Rank

medical Degrees

Sharon Ann Hunt

Philosophy

#7842

World Rank

#11108

Historical Rank

#1656

USA Rank

Logic

#4881

World Rank

#6213

Historical Rank

#838

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Sharon Ann Hunt's Degrees

Doctorate Medicine Harvard University
PhD Cardiology Stanford University

Why Is Sharon Ann Hunt Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sharon Ann Hunt is a cardiology professor and Director of the Post Heart Transplant Programme in Palo Alto, California and is affiliated with Stanford University Medical Center, professionally known for her work in the care of patients after heart transplantation.

(See a Problem?)

Sharon Ann Hunt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC (2006) (2631)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006) (2558)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (2315)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie (2007) (1962)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (1807)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (1569)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (1407)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006) (1406)
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. (2010) (1318)
Right Ventricular Function in Cardiovascular Disease, Part I: Anatomy, Physiology, Aging, and Functional Assessment of the Right Ventricle (2008) (1292)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (1224)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (1197)
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary (2010) (1162)
Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure (2008) (1102)
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008) (872)
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemaker (2008) (866)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (847)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co (2003) (786)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (769)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co (2003) (731)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (618)
Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. (1988) (499)
Mitral Valve Prolapse in One Hundred Presumably Healthy Young Females (1976) (437)
[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. (2006) (412)
Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. (2007) (391)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. (2006) (378)
Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease (2010) (378)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. (1993) (315)
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. (1982) (297)
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. (1999) (287)
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. (2001) (269)
Transplant coronary artery disease: histopathologic correlations with angiographic morphology. (1991) (265)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel (2006) (244)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. (1987) (214)
Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. (1988) (206)
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. (1989) (201)
The changing face of heart transplantation. (2008) (200)
Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. (1995) (187)
Complications in long-term survivors of cardiac transplantation. (1981) (177)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary (2011) (162)
Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. (1995) (159)
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. (1996) (155)
Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. (1992) (152)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (151)
Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. (1997) (146)
Mechanical circulatory support and cardiac transplantation. (1998) (145)
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone (2001) (144)
Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease: A Prospective Study (2001) (138)
A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Etiology and prognosis of restrictive-constrictive physiology. (1989) (138)
Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. (2005) (133)
Acute myocardial infarction in cardiac transplant recipients. (1989) (122)
Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review. (2018) (118)
Progressive coronary luminal narrowing after cardiac transplantation. (1990) (115)
Thirty years of cardiac transplantation at Stanford university. (1999) (113)
Current status of cardiac transplantation. (1998) (112)
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. (1987) (108)
Simultaneous Assessment of Fractional and Coronary Flow Reserves in Cardiac Transplant Recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study) (2003) (106)
Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. (1997) (103)
Taking heart--cardiac transplantation past, present, and future. (2006) (102)
Heart retransplantation: the 25-year experience at a single institution. (1995) (99)
Early development of accelerated graft coronary artery disease: risk factors and course. (1996) (99)
Cardiac transplantation: the Stanford experience in the cyclosporine era. (1994) (99)
Severe tricuspid regurgitation after heart transplantation. (2001) (97)
Cardiac sarcoidosis: response to steroids and transplantation. (1987) (86)
Guidelines for the Management of Patients With Supraventricular Arrhythmias * — Executive Summary (2003) (78)
Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. (1987) (77)
Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. (2006) (77)
Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors. (1996) (75)
Physiologic aspects of human heart-lung transplantation. Pulmonary function status of the post-transplanted lung. (1984) (74)
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD (2017) (74)
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. (2004) (71)
Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery? (2012) (71)
Long-term results of heart transplantation in patients older than 60 years. (2003) (70)
The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients: Results From a Multicenter Registry (2009) (64)
Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. (1991) (63)
Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (2006) (63)
Coronary artery spasm in the denervated transplanted human heart: a clue to underlying mechanisms. (1981) (62)
Metabolic risk factors for atherosclerosis in heart transplant recipients. (1994) (62)
Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. (1993) (61)
Major advantages and critical challenge for the proposed United States heart allocation system. (2016) (61)
24th Bethesda Conferences: Cardiac transplantation (1993) (60)
Predictors of survival after repeat heart transplantation (1992) (60)
Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. (1989) (60)
Influence of recipient atrial contraction on left ventricular filling dynamics of the transplanted heart assessed by Doppler echocardiography. (1987) (60)
Clinical and Functional Correlates of Early Microvascular Dysfunction After Heart Transplantation (2012) (60)
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. (2016) (59)
Long-term results, hemodynamics, and complications after combined heart and lung transplantation. (1985) (58)
The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation. (2011) (58)
A single non‐invasive model to diagnose non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) (2014) (58)
Successful retransplantation of the human heart. (1977) (57)
The Economic Implications of Noninvasive Molecular Testing for Cardiac Allograft Rejection (2005) (56)
Accelerated atherosclerosis in a cardiac transplant patient. (1985) (54)
Cardiovascular management of a potential heart donor: a statement from the Transplantation Committee of the American College of Cardiology. (1996) (54)
Changes in coronary anatomy and physiology after heart transplantation. (2007) (53)
Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study. (2000) (52)
Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. (2000) (51)
The impact of brain death on survival after heart transplantation: time is of the essence (2003) (51)
Outcome in Cardiac Recipients of Donor Hearts With Increased Left Ventricular Wall Thickness (2007) (50)
COMBINED HEART AND LUNG TRANSPLANTATION (1983) (50)
Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. (1990) (50)
Heart-lung transplantation for irreversible pulmonary hypertension. (1984) (49)
Characteristics of patients surviving more than ten years after cardiac transplantation. (1995) (48)
Accelerated graft coronary artery disease: diagnosis and prevention. (1992) (47)
Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. (2004) (46)
Increasing pericardial effusion in cardiac transplant recipients. (1989) (46)
Changing trends in infectious disease in heart transplantation. (2010) (46)
Cardiac transplantation in patients with preexisting neoplastic diseases. (1990) (45)
Superiority of Interferon-Free Regimens for Chronic Hepatitis C (2017) (44)
The Status of Cardiac Transplantation, 1975 (1975) (44)
The REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure (2002) (43)
Circulating levels of vasoactive intestinal polypeptide in liver disease. (1979) (43)
Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. (1983) (43)
Long-term outcome after heart transplantation for peripartum cardiomyopathy. (1994) (42)
Clinical heart-lung transplantation. (1984) (41)
Twenty‐Year Survivors of Heart Transplantation at Stanford University (2008) (40)
Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. (1995) (40)
Total lymphoid irradiation for treatment of intractable cardiac allograft rejection. (1991) (40)
Does rapidity of development of transplant coronary artery disease portend a worse prognosis? (1994) (39)
Effect of a change in gender on coronary arterial size: a longitudinal intravascular ultrasound study in transplanted hearts. (2003) (39)
Cardiac transplantation: where are we? (1986) (39)
Chest pain in heart-transplant recipients. (1991) (39)
Infections after cardiac transplantation: relation to rejection therapy. (1976) (38)
Mechanical circulatory support: new data, old problems. (2007) (37)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications (2002) (37)
In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered (2018) (36)
Cyclosporine in heart and heart-lung transplantation. (1985) (35)
Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. (2008) (34)
Cardiac transplantation. Update 1987. (1987) (33)
Does cardiac transplantation prolong life and improve its quality? An updated report. (1976) (33)
The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation. (2010) (32)
Cardiac transplantation in children and adolescents. (1987) (32)
Destination mechanical circulatory support: proposal for clinical standards. (2003) (31)
Characteristics of serial electrocardiograms in heart transplant recipients. (1991) (31)
Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. (1995) (31)
[Evidence-based management of right heart failure: a systematic review of an empiric field]. (2010) (30)
State of the art: cardiac transplantation. (2014) (30)
Health-related Quality of Life in Adolescent Patients With Hepatitis C Genotype 1 Treated With Sofosbuvir and Ledipasvir (2018) (30)
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. (2001) (29)
Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. (1997) (29)
Functional and social rehabilitation of heart transplant recipients under age thirty. (1984) (29)
Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. (2009) (28)
Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. (1997) (28)
24th Bethesda conference: Cardiac transplantation. Task Force 1: Organization of heart transplantation in the U.S. (1993) (28)
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. (1997) (27)
Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. (1996) (26)
Long‐term Survival and Function after Cardiac Transplantation (1981) (26)
Emergency department presentation and care of heart and heart/lung transplant recipients. (1992) (25)
Importance of decreased heart rate in predicting transplant coronary artery disease. (1997) (24)
Long-term results of cardiac transplantation. (1991) (24)
Prevalence, patterns of development, and prognosis of right bundle branch block in heart transplant recipients. (2006) (23)
Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. (2002) (23)
Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. (2005) (22)
Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease. (2000) (22)
Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators. (1992) (22)
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. (2007) (22)
Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography. (1995) (21)
Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study (2016) (21)
Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy. (2011) (21)
Heart failure overview. (2004) (20)
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. (2003) (20)
Dermatologic complications following heart transplantation. (1986) (19)
Mycophenolic acid concentrations in long‐term heart transplant patients: relationship with calcineurin antagonists and acute rejection (2002) (19)
Malignancy in organ transplantation: heart. (2002) (18)
The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era. (1990) (18)
Heart Failure Management: Caregiver Versus Care Plan (2003) (18)
The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung disease. (2010) (18)
Cardiovascular physiology in a case of heterotopic cardiac transplantation. (1982) (17)
Noninvasive assessment of donor and native heart function after heterotopic heart transplantation. (1988) (16)
Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. (2013) (16)
Comment--the REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure. (2002) (16)
Increased rejection in gender-mismatched grafts: amelioration by triple therapy. (1991) (16)
Molecular testing and prediction of clinical outcome in heart transplantation: a prospective multicenter trial (2004) (15)
Pulmonary hypertension in severe congestive heart failure: how important is it? (1997) (15)
Accelerated transplant coronary artery disease. (1990) (15)
Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors. (2016) (15)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) (15)
Are heart-lung transplant recipients protected from developing transplant coronary artery disease? A case-matched intracoronary ultrasound study. (1996) (15)
Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity. (1987) (14)
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. (2003) (14)
Spanish Heart Transplant Units Consensus Conference (2007) (14)
Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium? (2014) (14)
Circulatory Effects of Diazepam in Heart Disease (1976) (14)
Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. (2006) (14)
Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. (1998) (13)
Using Multiple Databases to Produce Comprehensive Follow‐Up in an Effort to Enhance Evaluation of Outcome Measurements: Surgical Ablation (Maze) Exemplar (2011) (13)
Behcet's disease and heart transplantation: a word of caution. (2010) (13)
Pregnancy in heart transplant recipients: a good idea? (1991) (12)
ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report. (2013) (12)
Quality of life and metrics of achievement in long‐term adult survivors of pediatric heart transplant (2015) (12)
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. (2002) (12)
Innovations in Ventricular Assist Devices for End-Stage Heart Failure. (2019) (11)
Current role for surgery in treatment of lone atrial fibrillation. (2012) (11)
Survivors more than 10 years after heart transplantation in the cyclosporine era (2002) (10)
Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis. (2006) (10)
Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease (2015) (10)
Long-term cardiopulmonary function after human heart-lung transplantation. (1990) (10)
Detection of accelerated graft atherosclerosis importance of hemodynamic response to exercise (1988) (10)
Developed in Collaboration With the European Heart Rhythm Association and the Sudden Cardiac Death) Management of Patients With Ventricular Arrhythmias and the Prevention of Practice Guidelines (Writing Committee to Develop Guidelines for (2007) (9)
A fair way of donating hearts for transplantation (2000) (9)
Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. (2007) (9)
New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. (2000) (8)
Accelerated graft coronary artery disease (1995) (8)
Prognosis of patients with significant angiographically diagnosed cardiac allograft coronary disease (2002) (8)
Bispectral Index Monitoring to Facilitate Early Extubation Following Cardiovascular Surgery (2010) (8)
Neoplasia after heart transplantation. (2000) (8)
Heart and lung transplantation for pulmonary hypertension. (1984) (7)
Ventilator-Associated Pneumonia Among Cardiac Surgery Patients: What Can We Do for Prevention? (2013) (7)
A bridge far enough? (2012) (7)
Gene expression profiling of cardiac allograft recipients with mild acute cellular rejection (2005) (7)
Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease (2001) (7)
Cardiac function after domino-donor heart transplantation. (1992) (7)
Refining pathological classification of acute rejection in cardiac allograft recipients: a multicenter study using peripheral blood gene expression profiling (2004) (7)
ACC/AHA guidelines: A-, B-, C-, and D-based approach to chronic heart failure therapy (2006) (6)
Cardiac transplantation. (1981) (6)
Comparison of blood glucose management strategies to achieve control following cardiac surgery (computerized versus paper). (2010) (6)
Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease (2019) (6)
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 8: training in heart failure and transplantation. (1995) (6)
Conquering the first hurdles in cardiac transplantation: In the footprints of giants. (2017) (5)
ACUTE NORMOVOLEMIC HEMODILUTION DECREASES BLOOD PRODUCT USE AND POSTOPERATIVE MORTALITY AND MORBIDITY FOLLOWING CARDIAC SURGERY (2012) (5)
Does late switch to mycophenolate mofetil affect development of transplant coronary artery disease (2002) (5)
936-88 Relationship of Donor Age and Pre-existing Coronary Disease by Angiography and Intracoronary Ultrasound to Later Development of Cardiac Allograft Coronary Artery Disease (1995) (5)
Combined heart and lung transplantation. (1983) (5)
A Quality Improvement Project to Optimize Patient Outcomes Following the Maze Procedure (2009) (4)
Evaluation of resources for the promotion of continence in residential aged care, a national consultative approach (2005) (4)
Heart transplant recipient selection issues: limited assets, infinite possibilities. (2012) (4)
Cardiac Transplantation - Status in 2011 (2011) (4)
Conversion of cyclosporine to tacrolimus in heart transplant patients: a single center experience (2002) (4)
Cardiac Allograft Vasculopathy: It Really Has Changed Over Time. (2017) (4)
Women Leaders in Cardiac Transplantation. (2019) (4)
Hyperhomocysteinemia Is Common In Heart Transplant Patients But Is Not Correlated With Transplant Coronary Artery Disease (1999) (3)
Mild cardiac allograft coronary disease does not change the prognosis of patients after heart transplantation (2002) (3)
Primary Prevention of Heart Failure in Older Adults. (2015) (3)
MYCOPHENOLATE MOFETIL IS ASSOCIATED WITH LESS CARDIAC TRANSPLANT REJECTION THAN AZATHIOPRINE IN PATIENTS WITH RECURRENT REJECTIONS (1999) (3)
A Systematic Review Assessing the Impact of Chronic Hepatitis C on Health-Related Quality of Life and Patient-Reported Outcomes: 611 (2014) (3)
The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
Cardiac transplantation. Where do we stand? (1985) (2)
Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
Who and When to Consider for Heart Transplantation (2001) (2)
157: Early detection of cardiac allograft vasculopathy through gene expression profiling – insights of the CARGO study (2006) (2)
Coronary Angiography of Older Donor Hearts During Evaluation for Transplantation (2014) (2)
Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study (2003) (2)
812e The Use of Sofosbuvir and Velpatasvir is Associated With High Efficacy and Improvement in Patient-Reported Outcomes in Patients with Genotype 1, 2, 4, 5 and 6 Chronic Hepatitis C: Results from the ASTRAL-1 Clinical Trial (2016) (1)
Sofosbuvir/Velpatasvir (SOF/VEL) with or without Voxilaprevir (VOX) is Associated with Excellent Efficacy and Significant Improvements of Patient-Reported Outcomes (PROS) During Treatment and After Achieving Sustained Virologic Response (SVR) (2017) (1)
20-year survivors of heart transplantation at Stanford University (2009) (1)
Drug management of the cardiac transplant patient (1988) (1)
FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART (2009) (1)
Quality of Life and Metrics of Achievement in Long-Term Adult Survivors of Pediatric Heart Transplant (2014) (1)
Abstract 2411: The Importance of Right Ventricular Dysfunction in patients with Hemodynamically Compromising Rejection (2008) (1)
Impact of prophylactic immediate post-transplant genciclovir on development of transplant atherosclerosis: A randomized placebo-controlled study (1996) (1)
A single center experience with heart retransplantation: the 29 year experience at a single institution (1997) (1)
QT dispersion is not associated with sudden cardiac death or mortality in heart transplant recipients. (2008) (1)
Sustained Virologic Response (SVR) in Hepatitis C (HCV) Patients Does Not Demonstrate Differences in Physical Performance, Fatigue, Sleep, and Health-related Quality of Life (HRQL): 410 (2013) (1)
Treatment options for patients with severe myocardial failure: a review of the latest technology (1999) (1)
Adherence to Interferon (IFN) and Ribavirin (RBV)-Free Regimens for Treatment of Chronic Hepatitis C (CH-C): Are There Any Associations With Clinical and Patient-Reported Outcomes (PROs)?: 2145 (2015) (1)
Mental and Emotional Impairment in Patients With Hepatitis C Is Related to Lower Work Productivity: 2063 (2015) (1)
Left Atrial Appendage Thrombus and LAD Embolisation on Apixaban (2017) (1)
Implementation of Baby Boomer Hepatitis C (HCV) Screening and Linking to Care in Gastroenterology (GE) Practices: A Multicenter Pilot Study: 2097 (2015) (1)
Abstract 18614: Comparison of the New EuroSCORE II with the Original EuroSCORE and the Society of Thoracic Surgeons Risk Score (2012) (1)
813-1 Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients (2004) (1)
Ventilator-Associated Pneumonia Among Cardiac Surgery Patients: What More Can We Do for Prevention? (2010) (1)
162: Sirolimus Use in Heart Transplant Recipients Is Associated with a High Incidence of Adverse Reactions Requiring Drug Discontinuation (2008) (1)
PATIENT'S DISCHARGE DISPOSITION AND SURVIVAL FOLLOWING CORONARY ARTERY BYPASS SURGERY: DOES IT REALLY MATTER? (2011) (0)
751 Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin (2016) (0)
An Unusual Case ofHyperviscosity SyndromePresenting as Exercise InducedPulmonary Hypertension in aHeart Transplant Patient (2016) (0)
But I'm a doctor!! (2014) (0)
197: 27-Year Experience with Combined Heart-Lung Transplantation at Stanford University (2009) (0)
The Effect of Transducer Placement on the Echocardiographic Pattern of Mitral Valve Prolapse (1976) (0)
733-4 Induction of Inducible Nitric Oxide Synthase (iNOS) mRNA and Protein in the Human Cardiac Allograft is Associated with Increased Myocardial cGMP Levels and Echocardiographic LV Dysfunction (1995) (0)
Lessons from ESCAPE: the PAC may not kill, but when should we consider ‘tailored’ therapy? (2006) (0)
Improved Heart Transplant Survival in Patients Bridged with Ventricular Assist Device (2002) (0)
RECONSTRUCTING THE CREB-NETWORK FROM 285 LEUKOCYTE-ARRAYS in CARGO YIELDS INSIGHT INTO TRANSCRIPTION FACTOR FUNCTION DURING QUIESCENCE AND REJECTION. (2006) (0)
THE COX MAZE PROCEDURE FOR STAND ALONE ATRIAL FIBRILLATION (2012) (0)
Less Risky Immunosuppression in Heart Transplantation? (2019) (0)
THE SIGNIFICANCE OF PREOPERATIVE SPIROMETRY IN ACCURATELY STRATIFYING THE PREDICTED RISK FOR ADVERSE OUTCOMES IN CARDIAC SURGERY PATIENTS (2009) (0)
IMPROVEMENT IN RIGHT HEART FAILURE AFTER TRICUSPID VALVE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS (1999) (0)
THERAPY AND PREVENTION CARDIAC TRANSPIANTATION Long-term results, hemodynamics, and complications after combined heart and lung transplantation (2005) (0)
GLUCOSE INTOLERANCE AS REFLECTED BY HEMOGLOBIN A1C IS SIGNIFICANTLY ASSOCIATED WITH A HIGH INCIDENCE OF TRANSPLANT CORONARY ARTERY DISEASE (1999) (0)
Long-term Outcome After Heart Transplantation for Peripartum Cardiomyopathy (1995) (0)
Has newer therapies improved the survival of cardiac death due to transplant coronary artery disease (2004) (0)
Precipitating Factors or Alternative Causes of Edema in eart Failure Non-compliance with diuretic ( and other ) medication Non-compliance with salt and fluid restriction Non-steroidal anti-inflammatory drug usage Glitazones Intrinsic renal disease (2006) (0)
Doppler and M-Mode Echocardiographic Assessment of Left Ventricular Function during Acute Cardiac Allograft Rejection (1987) (0)
Abstract 10678: How Well Does Patient Self Report of Rhythm Following the Cox-Maze Procedure Fair When Tested Against Long Term Monitoring at 6 Months? (2011) (0)
Right Ventricular Function in Cardiovascular Disease, Part II Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure Contemporary in Cardiovascular Medicine (2008) (0)
Long-term follow-up of the Stanford diltiazem for retardation and prevention of transplant coronary artery disease study (2005) (0)
PREOPERATIVE RISK FACTORS FOR ACUTE KIDNEY INJURY FOLLOWING CARDIAC CATHETERIZATION AND CABG (2009) (0)
DO LONG TERM RESULTS JUSTIFY PEDIATRIC HEART TRANSPLANTATION? (1987) (0)
The Role of Mannan Binding Lectin Pathway in Non-Alcoholic Fatty Liver Disease (NAFLD): 573 (2014) (0)
An Unusual Case of Hyperviscosity Syndrome Presenting as Exercise Induced Pulmonary Hypertension in a Heart Transplant Patient (2015) (0)
Will the Use of ICD 10 Codes Improve our Understanding of the Burden of Liver Disease in the United States?: 415 (2013) (0)
Anti-Adipocyte Antibodies (AdAb) Are Associated with Histological Features of Non Alcoholic Steatohepatitis (NASH): 421 (2013) (0)
Ventricular Function in Long-term Cardiac Allograft Recipients (2005) (0)
258: The importance of diabetes, biventricular failure and cellular infiltrates in hemodynamically compromising rejection (2007) (0)
LEUKOCYTE-ARRAYS in CARGO YIELDS INSIGHT INTO TRANSCRIPTION FACTOR FUNCTION DURING QUIESCENCE (2006) (0)
Abstract 2959: Granulocyte-Colony Stimulating Factor Therapy is Associated with Reduced Incidence of Acute Rejections and Allograft Vasculopathy in Heart Transplant Recipients (2008) (0)
9. Heart Transplantation (2011) (0)
Factors Associated with Long-Term (>10 Years) Survival after Heart Transplantation in the Cyclosporine Era : Stanford Experience (2003) (0)
Does statin therapy added to calcium channel blocker reduce development of transplant coronary artery disease in heart transplant survivors (2003) (0)
Norman E. Shumway, M.D., Ph.D. (1923–2006) (2006) (0)
27-year experience with combined heart-lung transplantation at Stanford University (2010) (0)
TACROLIMUS IS ASSOCIATED WITH IMPROVED VENTRICULAR SYSTOLIC AND DIASTOLIC CARDIAC ALLOGRAFT FUNCTION: ? DIRECT EFFECT ON MYOCYTE FUNCTION.: Abstract# 699 (2000) (0)
Abstract 4049: Cardiac Interventions Prior to Surgical Ablation for Atrial Fibrillation, Do Not Negatively Affect Outcomes (2009) (0)
Cardiac xenotransplantation. (2004) (0)
THE EARLY INTRODUCTION OF HMG-COA REDUCTASE INHIBITORS COULD PREVENT THE INCIDENCE OF TRANSPLANT CORONARY ARTERY DISEASE. (1999) (0)
Evaluation of 578,000 Patients From the National Inpatient Database on Changing Patient Clinical Profiles and Mortality After Coronary Artery Bypass Grafting Surgery Over a 10-Year Period (2010) (0)
Recurrent lymphoma in a cardiac allograft recipient. (1994) (0)
One Hundred Presumably Healthy Young Females (2005) (0)
Outcomes of patients with human immunodeficiency virus undergoing cardiac surgery (2010) (0)
Factors associated with long-term survival after heart transplantation in the cyclosporine era (2002) (0)
DISTINCT MOLECULAR PATHWAYS ARE ASSOCIATED WITH DIFFERENCES IN EFFICACY OF TACROLIMUS AND CYCLOSPORINE IN HEART TRANSPLANTATION (2004) (0)
Abstract 13101: Pre-Operative Complete Blood Count As a Predictor of Outcomes Prior to Isolated, First Time Coronary Artery Bypass Grafting Surgery (2010) (0)
Details of chapters, Coordinators, and Working Group members (2016) (0)
History of Heart Transplantation (2018) (0)
Abstract 18679: Stand Alone Cox-Maze Procedure for Patients with Non Paroxysmal Atrial Fibrillation- A Single Center Experience (2012) (0)
A Case of Giant Cell Myocarditis Presenting with Rapidly Progressive Conduction Disease and Heart Failure (2017) (0)
ADDITION OF THE COX MAZE PROCEDURE DOES NOT INCREASE RISK FOR MORBIDITY/MORTALITY FOLLOWING SURGERY INVOLVING THE MITRAL VALVE (2011) (0)
Successful Treatment with Sofosbuvir (SOF) Regimen Improves Patient-reported Outcomes (PROs) in Patients with Chronic Hepatitis C (CH-C): 482 (2013) (0)
Mo1169 Non-Alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes (DM): A Costly Combination (2016) (0)
Postoperative Management of Children Receiving Heart Transplants (1986) (0)
Abstract 2965: QT Interval Prolongation during Severe Acute Rejection is Predictive of Sudden Cardiac Death in Heart Transplant Recipients (2008) (0)
How to preserve information equity for COVID‐19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in Japan (2022) (0)
Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation (2013) (0)
Health-Related Quality of Life (HRQL) and Health Utilities (HU) of Patients with Chronic Hepatitis C (CH-C) Treated with an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir (SOF): 568 (2014) (0)
Improvement of survival and review of causes of death after heart transplantation: the Stanford experience 1980–1997 (2004) (0)
A Time Series Analysis of the Diet, Nutrition and Physical Activity Habits of Type 2 Diabetics: The Perfect Fuel for the Epidemic of Non-alcoholic Fatty Liver Disease (NAFLD): 426 (2013) (0)
28. A single center experience with heart retransplantation: the 29 year experience at (1997) (0)
GENDER DIFFERENCES IN PSYCHOSOCIAL PREDICTORS OF LONG-TERM QUALITY OF LIFE IN CARDIAC SURGERY PATIENTS (2012) (0)
Heart Failure Update (2005) (0)
Impact of new therapies on the prevalence of coronary artery disease in heart transplant survivors: stanford experience (2003) (0)
499 Ribavirin-Free Regimen With Velpatasvir and Sofosbuvir is Associated With High Efficiency and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From ASTRAL-2 and 3 Clinical Trials (2016) (0)
Cytomegalovirus burden and progressive severity of cardiac allograft vasculopathy (2004) (0)
Heart-lung transplantation at stanford university since 1981 (2009) (0)
Are we ready for building transition programs for heart transplant recipients in Japan? – Knowing the unique background is the first step for discussion (2022) (0)
Heart Transplantation in Childhood (2009) (0)
Tu1710 Liver-Type Fatty Acid Binding Protein (L- FABP) is Strongly Associated With Non-Alcoholic Steatohepatitis (NASH) (2016) (0)
End-stage renal failure and kidney transplantation in heart transplant recipients (2002) (0)
ForewordOne day update on heart failure (2006) (0)
Abstract 19286: Rhythm Results Following Surgical Ablation- How Should it Be Reported? (2012) (0)
494: Changing Trends in Infectious Complications among Heart Transplant Recipients (2009) (0)
Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection (2005) (0)
Hepatitis B (HBV) Viral Suppression is Independently Associated with Better Patient-Reported Outcomes (PROS) (2017) (0)
Abstract 21059: Are There Gender Differences in Outcomes Following Surgical Ablation? (2010) (0)
288: 20-Year Survivors of Heart Transplantation at Stanford University (2009) (0)
468: Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation (2009) (0)
Influence of brain death on survival after heart transplantation - time is of the essence (2002) (0)
Mo1526 Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography (2016) (0)
IS SERUM CREATININE <2.0 MG/DL SENSITIVE ENOUGH TO PREDICT ADVERSE OUTCOMES FOLLOWING CORONARY ARTERY BYPASS GRAFTING? ANOTHER LOOK AT THE ROLE OF GLOMERULAR FILTRATION RATE (2006) (0)
Mo1549 The Mucosal Addressin Cell Adhesion Molecule-1 (sMADCAM-1) and MAp44 Activation Are Associated With Different Clinical and Pathologic Features of Non Alcoholic Steatohepatitis (NASH) (2016) (0)
Abstract No. 204: Comparison of Outcomes between TIPS Performed with 8 mm and 10 mm Diameter Stent-Graft Devices (2008) (0)
Increasing Pericardial Effusion (2005) (0)
Abstract 18326: Elevated Right Ventricular Operant Diastolic Elastance Strongly Predicts Increased Risk of Mortality Following Heart Transplantation (2013) (0)
Physiologic interrogation of transplant arteriopathy: Final results (2003) (0)

This paper list is powered by the following services:

Other Resources About Sharon Ann Hunt

en.wikipedia.org

What Schools Are Affiliated With Sharon Ann Hunt?

Sharon Ann Hunt is affiliated with the following schools:

Sharon Ann Hunt's Academic­Influence.com Rankings

Sharon Ann Hunt's Degrees

Why Is Sharon Ann Hunt Influential?

Sharon Ann Hunt's Published Works

Published Works

Other Resources About Sharon Ann Hunt

What Schools Are Affiliated With Sharon Ann Hunt?

Sharon Ann Hunt's AcademicInfluence.com Rankings